HER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab

Affiliation auteurs!!!! Error affiliation !!!!
TitreHER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab
Type de publicationJournal Article
Year of Publication2020
AuteursVincent L, Jankowski C, Cortet M, Arnould L, Ladoire S, Coudert B, Desmoulins I, Charron-Barra C, Beltjens F, Rouzier R, Reyal F, Humbert O, Cochet A, Coutant C
JournalCANCER RESEARCH
Volume80
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.SABCS19-P2-16-14